Jury selection is scheduled to begin at 9 a.m. Tuesday in the second trial of the Crystal Rogers case. Brooks Houck and Joseph Lawson are being tried together.

Panelists discuss how treatment selection between combination immunotherapy (IO) and chemotherapy alone should favor the FDA-approved carboplatin-paclitaxel-retifanlimab regimen for most patients with ...